D
David Lawrence
Researcher at University of London
Publications - 37
Citations - 596
David Lawrence is an academic researcher from University of London. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 22 publications receiving 378 citations. Previous affiliations of David Lawrence include University of Sussex & Harvard University.
Papers
More filters
Journal ArticleDOI
Day care versus in‐patient surgery for age‐related cataract
TL;DR: The primary outcome was the achievement of a satisfactory visual acuity six weeks after the operation, and the findings for the other outcomes were inconclusive with wide CIs.
Journal ArticleDOI
Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus–associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial
Joseph N Jarvis,Tshepo B Leeme,Mooketsi Molefi,Awilly A Chofle,Gabriella Bidwell,Katlego Tsholo,Nametso Tlhako,Norah Mawoko,Raju K. K. Patel,Mark W Tenforde,Charles Muthoga,Gregory P. Bisson,Jeremiah Kidola,John Changalucha,David Lawrence,Shabbar Jaffar,William W. Hope,Siprimele F Molloy,Thomas S. Harrison +18 more
TL;DR: A phase II non-inferiority trial examined the early fungusicidal activity (EFA) of three short-course, high-dose liposomal amphotericin B (L-AmB) regimens for meningitis in HIV-infected adults in Tanzania and Botswana.
Journal ArticleDOI
Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes
Guan-Wee Wong,Tian Yeong,David Lawrence,Andrew D. Yeoman,Sumita Verma,Sumita Verma,Michael A. Heneghan +6 more
TL;DR: Concurrent extrahepatic autoimmune disease (CEHAID) associated with autoimmune hepatitis (AIH) have been incorporated into the diagnostic criteria stipulated by the International Autoimmune Hepatitis Group (IAIHG).
Journal ArticleDOI
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
Joseph N Jarvis,David Lawrence,David B. Meya,Enock Kagimu,John Kasibante,Edward Mpoza,M Rutakingirwa,Kenneth Ssebambulidde,Lillian Tugume,Joshua Rhein,David R. Boulware,Henry C. Mwandumba,Melanie Moyo,Henry Mzinganjira,Cecilia Kanyama,Mina C. Hosseinipour,Chimwemwe Chawinga,Graeme Meintjes,Charlotte Schutz,Kyla Comins,Achita Singh,Conrad Muzoora,Samuel Jjunju,Edwin Nuwagira,Mosepele Mosepele,Tshepo B Leeme,Keatlaretse Siamisang,Chiratidzo E. Ndhlovu,Admire Hlupeni,Constantine Mutata,Erik van Widenfelt,Tao Chen,Duolao Wang,W Hope,Timothée Boyer-Chammard,Angela Loyse,Síle F. Molloy,Nabila Youssouf,Olivier Lortholary,David G. Lalloo,Shabbar Jaffar,Thomas S. Harrison +41 more
TL;DR: Single dose liposomal amphotericin B (10mg/kg) on a backbone of flucytosine and fluconazole was non-inferior to the current WHO recommended standard of care for HIV-associated cryptococcal meningitis and associated with fewer adverse events.